While Novo Nordisk and Lilly are the undisputed leaders in weight management right now, a number of pharmaceutical companies ...
Nearly three quarters of U.S. adults are overweight or obese, according to a sweeping new study. The findings have ...
Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...
The Healthy on MSN14h
New Data: Nearly 50% of Weight-Loss Drug Patients Saw Lower Consumption of This, Too"For healthcare providers, these findings suggest that anti-obesity medications may offer dual benefits," one doctor reports ...
The rise in type 2 diabetes cases globally presents opportunities for growth in the market for GLP-1 drugs like Ozempic and ...
With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback